Analysed SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) News Sources
BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says
27-05-2026
yahoo.com
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
30-05-2026
yahoo.com
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
31-05-2026
yahoo.com
SMMT Stock Surges Overnight: Cancer Drug Survival Win Raises The Bar As PFE, BMY, MRK Chase Keytruda's Successor
01-06-2026
stocktwits.com
Wall Street Analysts Think Summit Therapeutics (SMMT) Could Surge 67.1%: Read This Before Placing a Bet
01-06-2026
yahoo.com
Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments
02-06-2026
yahoo.com
What is the current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is $15.07.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is $0.21.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is 1.4132%.
What is the most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is .
SEC-8K** Filing Available For SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.